37501 |
Multidisciplinary Sciences |
The incidence and clinical features of PEGylated filgrastim-induced ac... |
SCI REP-UK 2020 10.1038/s41598-020-75620-6 |
박연희 |
2020 |
37500 |
Oncology |
Prognostication of a 13-immune-related-gene signature in patients with... |
BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1 |
박연희 |
2020 |
37499 |
Oncology |
Olaparib and durvalumab in patients with germline BRCA-mutated metasta... |
LANCET ONCOL 2020 10.1016/S1470-2045(20)30324-7 |
박연희 |
2020 |
37498 |
Oncology; Immunology |
Clinical advantage of targeted sequencing for unbiased tumor mutationa... |
J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 |
박연희 |
2020 |
37497 |
Oncology; Health Care Sciences & Services; Rehabilitation |
Association between body image dissatisfaction and poor quality of lif... |
SUPPORT CARE CANCER 2020 10.1007/s00520-020-05884-1 |
장준호 |
2020 |
37496 |
Medicine, General & Internal |
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in Fir... |
NEW ENGL J MED 2020 10.1056/NEJMoa2004444 |
장준호 |
2020 |
37495 |
Medicine, General & Internal |
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia |
NEW ENGL J MED 2020 10.1056/NEJMoa2012971 |
장준호 |
2020 |
37494 |
Oncology |
Second-line cabozantinib after sorafenib treatment for advanced hepato... |
ESMO OPEN 2020 10.1136/esmoopen-2020-000714 |
임호영 |
2020 |
37493 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
임호영 |
2020 |
37492 |
Oncology |
Health-related quality-of-life impact of pembrolizumab versus best sup... |
CANCER 2020 10.1002/cncr.33317 |
임호영 |
2020 |